— Know what they know.
Not Investment Advice

AKAN NASDAQ

Akanda Corp.
1W: -35.1% 1M: -47.1% 3M: -83.7% YTD: -79.9% 1Y: -97.1% 3Y: -99.9%
$1.98
-0.23 (-10.41%)
 
Weekly Expected Move ±14.2%
$1 $2 $2 $2 $3
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 29 · $64085 mcap · 32174 float · 3225.93% daily turnover · Short 37% of daily vol

📊 Key Metrics

TTM
$1M
Revenue
-77.1% YoY
$-50M
Net Income
-13.1% YoY
$-14M
Free Cash Flow
-5.7% YoY
-350.2%
Gross Margin
-1445.0%
Op. Margin
-17342.7%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE679.7%
ROA-660.7%
ROIC-257.3%

Valuation

P/E-0.0
P/B-0.1
EV/EBITDA-1.8

Leverage

Debt/Equity-1.32
Current Ratio0.58
Interest Cov.-8.2x

Quality Scores

Piotroski F3/9
Altman Z-28.07
Beneish M-22.18

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms